Viral hepatitis in solid organ transplant recipients.
نویسندگان
چکیده
Hepatotropic viral infections are frequent in allograft recipients and may be caused by a number of different viruses. Of these, the most important infectious agents are hepatitis B virus (HBV) and hepatitis C virus (HCV), which can cause both acute and chronic hepatitis. In addition, Hepatitis E virus (HEV), thought previously to only cause acute hepatitis in the developing world, is emerging as an increasing cause of chronic hepatitis and even cirrhosis in solid organ transplant recipients in industrialized countries(Gerolami, Moal et al. 2008; Kamar, Mansuy et al. 2008; Gerolami, Moal et al. 2009; Haagsma, Niesters et al. 2009). Hepatitis D virus (HDV) additionally plays an important role in both coinfection and superinfection of HBV in solid organ transplant recipients. In addition to the primary viral hepatitis infections, a variety of other systemic viral infections, such as the herpesviruses, cytomegalovirus (CMV), Ebstein Barr Virus (EBV), and varicella zoster virus (VZV) can have toxic effects on the liver in the posttransplant recipient. This chapter will focus primarily on the epidemiology, transmission, clinical presentation and management of the primary hepatitis viruses: HBV, HCV, HDV and HEV, following solid organ transplantation. General concepts in the prevention of post-transplant hepatotropic infections and recent advances and challenges will also be discussed.
منابع مشابه
Acute liver failure secondary to opportunistic viral infection in adult solid organ transplant recipients.
Acute liver failure (ALF) is the product of a rapid, overwhelming insult to the liver that destroys parenchymal function, resulting in a multisystem illness characterized by coagulopathy and encephalopathy. Viral infections and drug induced liver injury are the most common causes of ALF. The most common viral precipitants are the hepatotropic viruses, hepatitis A, B and E (ALF due to hepatitis ...
متن کاملThe Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus
The pan-protein kinase C (PKC) inhibitor sotrastaurin (AEB071) is a novel immunosuppressant currently in phase II trials for immunosuppression after solid organ transplantation. Besides T-cell activation, PKC affects numerous cellular processes that are potentially important for the replication of hepatitis B virus (HBV) and hepatitis C virus (HCV), major blood-borne pathogens prevalent in soli...
متن کاملHepatitis C virus infection and risk of post-transplant lymphoproliferative disorder among solid organ transplant recipients
متن کامل
Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France
The rate of transfusion-transmitted hepatitis E virus (HEV) in transplant recipients is unknown. We identified 60 HEV-positive solid organ transplant patients and retrospectively assessed their blood transfusions for HEV. Seven of 60 patients received transfusions; 3 received HEV-positive blood products. Transfusion is not the major route of infection in this population.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
دوره 9 Suppl 4 شماره
صفحات -
تاریخ انتشار 2009